Avanzanite Bioscience B.V., a pioneering commercial-stage specialty pharmaceutical company advancing life-changing medicines ...

Bona, a global, family-owned company that supplies products for installing, renovating, maintaining, and restoring premium floors, proudly announces its sponsorship of the Nordic Pavillion at the ...

Ares Management Corporation (NYSE: ARES) (“Ares”), a leading global alternative investment manager, announced today that its Ares European Strategic Income Fund (“AESIF”), an open-ended direct lending ...

In an era where governance, technology, and economic resilience define the future of nations, the World Governments Summit ...

Celonis, the global leader in Process Mining and Process Intelligence, today announced the appointment of Daniel Brown as ...

TransRe today announced changes within its executive team, including the promotions of Louise Rose and Kyle Rhodes, and the retirement of Andy Taylor after a distinguished career with the company.

Forrester (Nasdaq: FORR) forecasts that e-commerce sales across the Europe-5 economies — France, Germany, Italy, Spain and the UK — will grow at a compound annual growth rate (CAGR) of 7.8% over the ...

ELIQUENT Life Sciences (ELIQUENT), a global regulatory, quality, and safety consulting firm, today announced the appointment of Rob Wojciechowski as Chief Operations Officer (COO). In this new role, ...

Innovaderm Research, a leader in dermatological and rheumatological research, is proud to announce the appointment of Jeff Smith as the new CEO of the organization. This strategic change allows ...

TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has partnered with, Avantor, Inc. (NYSE: AVTR), a leading ...

The Estée Lauder Companies Inc. (NYSE: EL) today announced that Michael Bowes has been appointed Executive Vice President, Chief People Officer, effective April 1, 2025, reporting directly to ...

AdvanCell, a clinical-stage radiopharmaceutical company developing innovative cancer therapeutics, today announced the successful completion of an oversubscribed US$112 million Series C financing.